286 related articles for article (PubMed ID: 17906625)
1. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
Cortina C; Palomo-Ponce S; Iglesias M; Fernández-Masip JL; Vivancos A; Whissell G; Humà M; Peiró N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E
Nat Genet; 2007 Nov; 39(11):1376-83. PubMed ID: 17906625
[TBL] [Abstract][Full Text] [Related]
2. EphB receptor activity suppresses colorectal cancer progression.
Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H
Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414
[TBL] [Abstract][Full Text] [Related]
3. EphB/EphrinB receptors and Wnt signaling in colorectal cancer.
Clevers H; Batlle E
Cancer Res; 2006 Jan; 66(1):2-5. PubMed ID: 16397205
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.
Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H
Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
Berardi AC; Marsilio S; Rofani C; Salvucci O; Altavista P; Perla FM; Diomedi-Camassei F; Uccini S; Kokai G; Landuzzi L; McDowell HP; Dominici C
Anticancer Res; 2008; 28(2A):763-9. PubMed ID: 18507018
[TBL] [Abstract][Full Text] [Related]
6. The Intestinal Wnt/TCF Signature.
Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
8. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
[TBL] [Abstract][Full Text] [Related]
10. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
11. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
13. Induction of ephrin-B1 and EphB receptors during denervation-induced plasticity in the adult mouse hippocampus.
Wang Y; Ying GX; Liu X; Wang WY; Dong JH; Ni ZM; Zhou CF
Eur J Neurosci; 2005 May; 21(9):2336-46. PubMed ID: 15932593
[TBL] [Abstract][Full Text] [Related]
14. EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation.
Arthur A; Zannettino A; Panagopoulos R; Koblar SA; Sims NA; Stylianou C; Matsuo K; Gronthos S
Bone; 2011 Mar; 48(3):533-42. PubMed ID: 21056708
[TBL] [Abstract][Full Text] [Related]
15. Complementary expression of EphB receptors and ephrin-B ligand in the pyloric and duodenal epithelium of adult mice.
Ishii M; Nakajima T; Ogawa K
Histochem Cell Biol; 2011 Sep; 136(3):345-56. PubMed ID: 21818578
[TBL] [Abstract][Full Text] [Related]
16. In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes.
Jiang G; Freywald T; Webster J; Kozan D; Geyer R; DeCoteau J; Narendran A; Freywald A
Mol Cancer Res; 2008 Feb; 6(2):291-305. PubMed ID: 18314490
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
18. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
[TBL] [Abstract][Full Text] [Related]
19. Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord.
Jevince AR; Kadison SR; Pittman AJ; Chien CB; Kaprielian Z
J Comp Neurol; 2006 Aug; 497(5):734-50. PubMed ID: 16786562
[TBL] [Abstract][Full Text] [Related]
20. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
